Almirall, BioFocus enter three-year drug discovery alliance

Spain’s Almirall has consolidated its existing relationship with BioFocus, the UK-based drug discovery specialist and Galapagos affiliate, by announcing a three-year research alliance aimed at delivering “drug development candidates directed to a key respiratory target of interest to Almirall”. The collaboration could be worth as much as €7.5 million to BioFocus, which will apply its

Continue Reading

Almirall Start Phase III trials & Announce Collaboration with BioFocus

Spain’s Almirall yesterday announced that they have linked up with UK drug discovery firm BioFocus to find new hit compounds against key targets of interest to Almirall.  These compounds will be used to support projects targeted at the treatment of respiratory and inflammatory conditions. BioFocus, the service division of Belgium’s Galapagos, will apply their screening

Continue Reading